Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Nature Communications|February 27, 2024
Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturationStefanie Kirchberger, Mohamed R Shoeb, Daria Lazic, et al.
Development (Cambridge, England)|March 12, 2015
Gata2b is a restricted early regulator of hemogenic endothelium in the zebrafish embryoEmerald Butko, Martin Distel, Claire Pouget, et al.
European Journal of Medicinal Chemistry|October 10, 2024
Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective bindersJaka Dernovšek, Tjaša Goričan, Marius Gedgaudas, et al.
Cancer Letters|December 3, 2022
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcomaSarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, et al.
Molecular Metabolism|August 28, 2021
An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturationTamara Casteels, Yufeng Zhang, Thomas Frogne, et al.
Nature Communications|January 16, 2023
Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal speciesJohanna Klughammer, Daria Romanovskaia, Amelie Nemc, et al.
Acta Neuropathologica Communications|April 28, 2022
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasivenessLisa Gabler, Carola Nadine Jaunecker, Sonja Katz, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Pageof 8